What is the address of Debeuckelaere Celine, gastro-enteroloog?

The registered office of Debeuckelaere Celine, gastro-enteroloog is located at Pontweg 163, 9310 Aalst.

Is Debeuckelaere Celine, gastro-enteroloog still active?

Yes. According to the CBE (1 October 2026) Debeuckelaere Celine, gastro-enteroloog is active, legal situation “Normale toestand”, started on 16 September 2021.

Is Debeuckelaere Celine, gastro-enteroloog registered on Peppol?

No, Debeuckelaere Celine, gastro-enteroloog is currently not registered on the Peppol network.

What is the enterprise number of Debeuckelaere Celine, gastro-enteroloog?

The enterprise number of Debeuckelaere Celine, gastro-enteroloog is BE0773954981.

When was Debeuckelaere Celine, gastro-enteroloog founded?

Debeuckelaere Celine, gastro-enteroloog was founded on 16 September 2021.

Is Debeuckelaere Celine, gastro-enteroloog a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 16 September 2021; 4 annual accounts filed, latest fiscal year 2025.

How much profit did Debeuckelaere Celine, gastro-enteroloog make in 2025?

Debeuckelaere Celine, gastro-enteroloog posted a profit after taxes of € 121,876 in financial year 2025.

What is the revenue of Debeuckelaere Celine, gastro-enteroloog?

As a small company, Debeuckelaere Celine, gastro-enteroloog is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 180,161.

Debeuckelaere Celine, gastro-enteroloog (Private Limited)

Dossier Debeuckelaere Celine, gastro-enteroloog, printed on 1 October 2026 from databakkes.be/en/0773954981/debeuckelaere-celine-gastro-enteroloog. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

Debeuckelaere Celine, gastro-enteroloog from Aalst, company number BE0773954981, closed financial year 2025 with a result of € 121,876 after tax. For that financial year Debeuckelaere Celine, gastro-enteroloog recorded a gross margin of € 180,161 and equity of € 99,041. Compared with financial year 2024, the result moved from € 124,108 to € 121,876. The company is profitable. The buffer shrank hard: equity is 71 % below last year. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 24, 2026.

What it is worth Shrank hard

€ 99,041

▼ 71% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 121,876

▼ 2% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 331,723

▲ 6% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 360,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 49,283

▼ 30% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 3 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 42,528

▼ 35% vs 2024

€ 14,925 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Taxes

€ 14,397

▲ 161% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 154,829 Gross margin 2022: € 154,829 First fiscal year in the series	€ 144,654 Gross margin 2023: € 144,654 ▼ 7% vs 2022 (€ 154,829) Unfavourable step	€ 191,062 Gross margin 2024: € 191,062 ▲ 32% vs 2023 (€ 144,654) Favourable step	€ 180,161 Gross margin 2025: € 180,161 ▼ 6% vs 2024 (€ 191,062) Unfavourable step	▼ 6%
Profit after taxes	€ 117,623 Profit after taxes 2022: € 117,623 First fiscal year in the series	€ 97,434 Profit after taxes 2023: € 97,434 ▼ 17% vs 2022 (€ 117,623) Unfavourable step	€ 124,108 Profit after taxes 2024: € 124,108 ▲ 27% vs 2023 (€ 97,434) Favourable step	€ 121,876 Profit after taxes 2025: € 121,876 ▼ 2% vs 2024 (€ 124,108) Unfavourable step	▼ 2%
Equity	€ 122,623 Equity 2022: € 122,623 First fiscal year in the series	€ 220,057 Equity 2023: € 220,057 ▲ 79% vs 2022 (€ 122,623) Favourable step	€ 337,165 Equity 2024: € 337,165 ▲ 53% vs 2023 (€ 220,057) Favourable step	€ 99,041 Equity 2025: € 99,041 ▼ 71% vs 2024 (€ 337,165) Unfavourable step	▼ 71%
Total debts	€ 9,792 Total debts 2022: € 9,792 First fiscal year in the series	€ 83,901 Total debts 2023: € 83,901 ▲ € 74,109 vs 2022 (€ 9,792) Unfavourable step	€ 76,724 Total debts 2024: € 76,724 ▼ 9% vs 2023 (€ 83,901) Favourable step	€ 310,712 Total debts 2025: € 310,712 ▲ € 233,987 vs 2024 (€ 76,724) Unfavourable step	▲ € 233,987
Cash	€ 82,406 Cash 2022: € 82,406 First fiscal year in the series	€ 174,578 Cash 2023: € 174,578 ▲ 112% vs 2022 (€ 82,406) Favourable step	€ 311,623 Cash 2024: € 311,623 ▲ 79% vs 2023 (€ 174,578) Favourable step	€ 331,723 Cash 2025: € 331,723 ▲ 6% vs 2024 (€ 311,623) Favourable step	▲ 6%
Land & buildings	€ 38,693 Land & buildings 2022: € 38,693 First fiscal year in the series	€ 34,764 Land & buildings 2023: € 34,764 ▼ 10% vs 2022 (€ 38,693) Unchanged	€ 30,835 Land & buildings 2024: € 30,835 ▼ 11% vs 2023 (€ 34,764) Unchanged	€ 26,906 Land & buildings 2025: € 26,906 ▼ 13% vs 2024 (€ 30,835) Unchanged	▼ 13%
Retained profit	€ 117,623 Retained profit 2022: € 117,623 First fiscal year in the series	€ 215,057 Retained profit 2023: € 215,057 ▲ 83% vs 2022 (€ 117,623) Favourable step	€ 332,165 Retained profit 2024: € 332,165 ▲ 54% vs 2023 (€ 215,057) Favourable step	€ 94,041 Retained profit 2025: € 94,041 ▼ 72% vs 2024 (€ 332,165) Unfavourable step	▼ 72%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 7,000 Dividend 2024: € 7,000 Unchanged (€ 0) Unchanged	€ 360,000 Dividend 2025: € 360,000 ▲ € 353,000 vs 2024 (€ 7,000) Unchanged	▲ € 353,000
Bank debt	€ 8,532 Bank debt 2022: € 8,532 First fiscal year in the series	€ 79,307 Bank debt 2023: € 79,307 ▲ € 70,776 vs 2022 (€ 8,532) Unfavourable step	€ 65,386 Bank debt 2024: € 65,386 ▼ 18% vs 2023 (€ 79,307) Favourable step	€ 42,528 Bank debt 2025: € 42,528 ▼ 35% vs 2024 (€ 65,386) Favourable step	▼ 35%
Balance sheet total	€ 132,415 Balance sheet total 2022: € 132,415 First fiscal year in the series	€ 303,958 Balance sheet total 2023: € 303,958 ▲ 130% vs 2022 (€ 132,415) Unchanged	€ 413,889 Balance sheet total 2024: € 413,889 ▲ 36% vs 2023 (€ 303,958) Unchanged	€ 409,752 Balance sheet total 2025: € 409,752 ▼ 1% vs 2024 (€ 413,889) Unchanged	▼ 1%

Key figures of Debeuckelaere Celine, gastro-enteroloog, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Debeuckelaere Celine, gastro-enteroloog?

What happened at Debeuckelaere Celine, gastro-enteroloog in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 24, 2026 New annual accounts for financial year 2025: profit of € 121,876 (▼ 2% vs 2024). Source: NBB ↗
Sep 16, 2021 New establishment in Aalst. KBO
Sep 16, 2021 Start of the company according to the CBE. KBO

In short

From € 117,623 profit in 2022 to € 121,876 profit in 2025.

Paid € 138,258 in corporate taxes since 2022.

Best year ever: 2024, with € 124,108 profit.

Paid out € 367,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Debeuckelaere Celine, gastro-enteroloog? We notify you, reason included.

Follow Debeuckelaere Celine, gastro-enteroloog

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Establishments

Establishment units

Physical locations of this company

Registered office

Pontweg 163

9310 Aalst

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

van den Broek Mathias, Orthopedie

€ 354,745 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0773.954.981
VAT number: BE 0773.954.981
Registered office: Pontweg 163, 9310 Aalst
Names & denominations: Debeuckelaere Celine, gastro-enteroloog
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 16 September 2021
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗

Debeuckelaere Celine, gastro-enteroloog